Hypocellular acute myeloid leukemia treated with bone marrow transplantation. Issue 4 (April 2017)

• Record Type: Journal Article
• Authors: Keino, Dai; Kondoh, Kensuke; Ohyama, Ryo; Morimoto, Mizuho; Mori, Tetsuya; Ito, Masafumi; Kinoshita, Akitoshi
• Is Part Of: Pediatrics international. Volume 59:Issue 4(2017)
• Page Start: 490
• Page End: 493
• Publication Date: 2017-04
• Subjects: bone marrow transplantation -- childhood -- hypocellular acute myeloid leukemia -- hypoplastic bone marrow; Pediatrics -- Periodicals; 618.92
• DOI: 10.1111/ped.13237
• Languages: English
• ISSNs: 1328-8067

Abstract

Abstract: Hypocellular acute myeloid leukemia (AML) mainly occurs in elderly patients, and is extremely rare in childhood. There is still no established treatment for hypocellular AML. We report the case of an 11‐year‐old boy with hypocellular AML who was treated successfully with allogenic bone marrow transplantation (allo‐BMT). He presented with fever, pallor and pancytopenia. Bone marrow aspiration and biopsy confirmed a diagnosis of hypocellular AML. Although low‐dose cytarabine induced reduction of blasts, it did not lead to complete remission. He subsequently received myeloablative conditioning and allo‐BMT. Graft‐versus‐host disease (GVHD) prophylaxis included short‐course methotrexate and cyclosporine. Neutrophil engraftment (>5 × 10 8 /L) and platelet recovery (>10 × 10 10 /L) were achieved on days 13 and 27, respectively. He developed acute GVHD of the skin (grade 2), which responded well to treatment with prednisolone. He has remained in complete remission for 5 years since allo‐BMT. We consider allo‐BMT to be feasible for children with hypocellular AML.